Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Female Breast Cancer 1 Breakthrough Pain 1

Interventions

Passive Cutaneous Anaphylaxis 1 Infusions, Intravenous 1 Fentanyl 1 Administration, Sublingual 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breakthrough Pain × Fentanyl × Clear all

NCT03809455 2020-04-22

FARADI

UNICANCER

Phase 2 Withdrawn

Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡